A novel treatment approach using vitamin B12‐conjugated sericin for mitigating nanodiamond‐induced toxicity in darkling beetles

Abstract

AbstractThe escalating use of nanodiamonds (NDs) has raised concerns about their ecotoxicological impact, prompting exploration of therapeutic interventions. This paper pioneers the examination of Vitamin B12‐conjugated sericin (VB12‐SER) as a potential therapeutic approach against ND‐induced toxicity in darkling beetles (Blaps polychresta). The study analyzes mortality rates and organ‐specific effects, covering the testis, ovary, and midgut, before and after treatments. Following exposure to 10 mg NDs/g body weight, within a subgroup of individuals termed ND2 with a mortality rate below 50%, two therapeutic treatments were administered, including pure sericin (SER) at 10 mg/mL and VB12‐SER at 10.12 mg/mL. Consequently, five experimental groups (control, SER, ND2, ND2+SER, ND2+SER+VB12) were considered. Kaplan–Meier survival analysis was performed to assess the lifespan distribution of the insects in these groups over a 30‐d period. Analyses revealed increased mortality and significant abnormalities induced by NDs within the examined organs, including cell death, DNA damage, enzyme dysregulation, antioxidant imbalances, protein depletion, lipid peroxidation, and morphological deformities. In contrast, the proposed treatments, especially (ND2+SER+VB12), demonstrated remarkable recovery, highlighting VB12‐conjugated SER's potential in mitigating ND‐triggered adverse effects. Molecular docking simulations affirmed binding stability and favorable interactions of the VB12‐SER complex with target proteins. This research enhances understanding of NDs’ effects on B. polychresta, proposing it as an effective bioindicator, and introduces VB12‐conjugated SER as a promising therapeutic strategy in nanotoxicological studies.